Clinical Trials Directory

Trials / Completed

CompletedNCT01180010

Low Dose Chest Computed Tomography (CT) Screening

Low-Dose Chest CT for Lung Cancer Screening in Survivors of Hodgkin's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research study is being done because patients with a history of chest radiation treatment for Hodgkin's disease have been shown to be at increased risk for developing lung cancer a number of years out from treatment. The risk appears to be further increased among patients with a smoking history. In this study, the CT scans will be read and interpreted by the study radiologist, and the results recorded in a consistent manner. Depending on the findings of the initial CT scan, we will then either repeat the scan in 1 year, or if indicated, send you for further scans or a biopsy. The information collected in this study will help researchers and clinicians in providing more concrete recommendations and screening guidelines for future survivors of Hodgkin's disease who have had similar exposures to radiation and/or chemotherapy and smoking.

Conditions

Interventions

TypeNameDescription
PROCEDURELow Dose CTA chest CT uses special radiographic equipment using x-rays to capture images of the chest, and with the aid of a computer, processes the images to create cross-sectional pictures or "slices" of the areas of interest. The images can then be printed out or examined on a monitor. The CT scanner is a large unit with a hole running directly through its center, giving the appearance of a doughnut. During the scanning, patients will lie flat on their back on a table, and they are periodically asked to hold their breath. The table will first move through the scanner to determine the correct starting position. The rest of the scans are made as the table moves more slowly through the cavity in the scanner.

Timeline

Start date
2010-08-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2010-08-11
Last updated
2016-12-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01180010. Inclusion in this directory is not an endorsement.